Jessie Liyi Peng, NP
Nurse Practitioner · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 2 carriers
- Office
- 1
- Since medical school
- 7 years
- Graduated 2019
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Jessie Liyi Peng’s office at (650) 696-5400 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
State licence records
1 licence
- Washington ARNP.AP.60937038-NPAdvanced Registered Nurse Practitioner License · since 2019 · expires 2019-08-15ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$100,827
Medicare paid this office $100,827 for 440 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 333 | $55,208 | $132 |
| Transitional care management services for problem of high complexity | 66 | $16,004 | $232 |
| Telephone medical discussion with physician, 21-30 minutes | 74 | $8,544 | $103 |
| Return visit (30+ min) | 45 | $4,654 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $3,896 | $89 |
See all 11 services
| Long return visit (40+ min) | 333 | $55,208 | $132 |
| Transitional care management services for problem of high complexity | 66 | $16,004 | $232 |
| Telephone medical discussion with physician, 21-30 minutes | 74 | $8,544 | $103 |
| Return visit (30+ min) | 45 | $4,654 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $3,896 | $89 |
| Programming of dual lead pacemaker system | 42 | $2,735 | $64 |
| Hospital discharge day management, more than 30 minutes | 23 | $2,024 | $88 |
| Short return visit (20+ min) | 16 | $1,193 | $75 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 27 | $1,150 | $41 |
| Programming of dual lead implantable defibrillator system | 11 | $908 | $83 |
| Programming of single lead pacemaker system | 15 | $813 | $54 |
Who their Medicare patients are
440 Original Medicare patients in 2024. Average age 80 · 85 and older 29% · Women 46% · Also on Medicaid 13% · Health risk score 1.72. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Atrial fibrillation 75% · Heart failure 52% · Coronary heart disease 46% · Diabetes 39% · Chronic kidney disease 39% · Cancer 17% · COPD 17% · Depression 17% · Stroke 11% · Dementia 8%.
The office billed $376,361, Medicare allowed $134,777 and paid $100,827; for 849 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 440 | 849 | 80 | 1.72 | $376,361 | $100,827 |
| 2023 | 513 | 1,098 | 80 | 1.60 | $472,271 | $128,166 |
| 2022 | 240 | 440 | 78 | 1.64 | $164,238 | $42,472 |
| 2021 | 185 | 376 | 78 | 1.53 | $146,203 | $43,265 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Long return visit (40+ min) | 406 | $66,507 | $130 |
| Transitional care management services for problem of high complexity | 75 | $17,695 | $230 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 86 | $14,814 | $91 |
| Transitional care management services for problem of at least moderate complexity | 52 | $9,341 | $170 |
| Telephone medical discussion with physician, 21-30 minutes | 46 | $5,418 | $100 |
| Hospital discharge day management, 30 minutes or less | 64 | $4,020 | $62 |
| Return visit (30+ min) | 26 | $2,819 | $104 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 54 | $2,629 | $48 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,471 | $134 |
| Programming of dual lead pacemaker system | 16 | $1,080 | $68 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 15 | $839 | $56 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $190 | $12 |
2022: 6 services
| Long return visit (40+ min) | 190 | $29,542 | $128 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $6,059 | $75 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 40 | $2,163 | $47 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $1,328 | $95 |
| Return visit (30+ min) | 11 | $931 | $78 |
| Hospital observation care on day of discharge | 17 | $927 | $55 |
2021: 5 services
| Long return visit (40+ min) | 153 | $31,061 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $3,593 | $78 |
| Return visit (30+ min) | 31 | $3,465 | $102 |
| Hospital observation care on day of discharge | 17 | $948 | $56 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 18 | $815 | $45 |
Medicaid work
$44,356 in 2020
Medicaid paid $44,356 for 373 billed services this clinician did in 2020, up to 72 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 239 | $44,332 |
| Short return visit (20+ min) | 88 | $24 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 30 | $0 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 16 | $0 |
| 2020 | 373 | 4 | 72 | $44,356 |
| 2019 | 540 | 7 | 75 | $46,494 |
See the largest Medicaid services in earlier years
2019
| Clinic visit/encounter, all-inclusive | 279 | $46,323 |
| Short return visit (20+ min) | 92 | $146 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 74 | $18 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 13 | $7 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 32 | $0 |
| Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use | 15 | $0 |
| Return visit (30+ min) | 35 | $0 |
Drugs they prescribed that Part D paid
$758,044
Pharmacies billed $758,044 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,251 generic and 476 brand-name prescriptions · $758,044 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 391 | $561,954 | $1,437 |
| Xarelto | 55 | $75,604 | $1,375 |
| Dofetilide | 284 | $65,790 | $232 |
| Diltiazem 24hr Er (Cd) | 108 | $8,195 | $76 |
| Metoprolol | 257 | $4,363 | $17 |
See all 21 drugs
| Eliquis | 391 | $561,954 | $1,437 |
| Xarelto | 55 | $75,604 | $1,375 |
| Dofetilide | 284 | $65,790 | $232 |
| Diltiazem 24hr Er (Cd) | 108 | $8,195 | $76 |
| Metoprolol | 257 | $4,363 | $17 |
| Dabigatran Etexilate | 16 | $3,233 | $202 |
| Amiodarone | 106 | $3,225 | $30 |
| Sotalol | 91 | $1,528 | $17 |
| Flecainide Acetate | 31 | $1,232 | $40 |
| Sotalol Af | 24 | $1,170 | $49 |
| Colchicine | 20 | $820 | $41 |
| Diltiazem | 23 | $551 | $24 |
| Atorvastatin | 14 | $447 | $32 |
| Omeprazole | 37 | $315 | $9 |
| Metoprolol | 59 | $254 | $4 |
| Carvedilol | 18 | $212 | $12 |
| Pantoprazole | 18 | $138 | $8 |
| Spironolactone | 11 | $128 | $12 |
| Amlodipine Besylate | 13 | $89 | $7 |
| Potassium Chloride | 13 | $43 | $3 |
| Furosemide | 15 | $28 | $2 |
Year by year
| 2024 | 1,727 | 498 | None | 28% | $758,044 |
| 2023 | 1,472 | 401 | None | 23% | $510,213 |
| 2022 | 653 | 222 | 0% (0) | 21% | $169,194 |
| 2021 | 463 | 172 | None | None | $82,005 |
| 2020 | 128 | 22 | None | None | $12,127 |
| 2019 | 65 | 15 | 0% (0) | None | $3,628 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Eliquis | 271 | $340,903 | $1,258 |
| Dofetilide | 278 | $71,024 | $255 |
| Xarelto | 41 | $48,362 | $1,180 |
| Diltiazem 24hr Er (Cd) | 125 | $6,994 | $56 |
| Metoprolol | 169 | $3,755 | $22 |
| Amiodarone | 77 | $3,463 | $45 |
| Sotalol | 77 | $1,614 | $21 |
| Flecainide Acetate | 19 | $1,390 | $73 |
| Colchicine | 19 | $1,174 | $62 |
| Sotalol Af | 16 | $947 | $59 |
| Diltiazem | 22 | $783 | $36 |
| Omeprazole | 61 | $723 | $12 |
| Cartia Xt | 13 | $574 | $44 |
| Atorvastatin | 15 | $403 | $27 |
| Carvedilol | 19 | $346 | $18 |
| Nitroglycerin | 11 | $313 | $28 |
| Amlodipine Besylate | 20 | $247 | $12 |
| Metoprolol | 37 | $226 | $6 |
| Lisinopril | 17 | $207 | $12 |
| Pantoprazole | 15 | $187 | $12 |
| Furosemide | 26 | $154 | $6 |
| Potassium Chloride | 14 | $124 | $9 |
2022: 16 drugs
| Eliquis | 92 | $109,160 | $1,187 |
| Dofetilide | 73 | $22,142 | $303 |
| Xarelto | 11 | $11,227 | $1,021 |
| Diltiazem 24hr Er (Cd) | 75 | $3,285 | $44 |
| Amiodarone | 31 | $2,032 | $66 |
| Metoprolol | 65 | $1,499 | $23 |
| Sotalol | 40 | $872 | $22 |
| Omeprazole | 37 | $364 | $10 |
| Diltiazem | 16 | $243 | $15 |
| Carvedilol | 18 | $217 | $12 |
| Losartan | 21 | $216 | $10 |
| Lisinopril | 11 | $139 | $13 |
| Metoprolol | 18 | $127 | $7 |
| Amlodipine Besylate | 15 | $117 | $8 |
| Furosemide | 17 | $82 | $5 |
| Potassium Chloride | 14 | $59 | $4 |
2021: 12 drugs
| Eliquis | 59 | $53,158 | $901 |
| Dofetilide | 45 | $7,317 | $163 |
| Diltiazem 24hr Er (Cd) | 40 | $2,204 | $55 |
| Amiodarone | 23 | $887 | $39 |
| Metoprolol | 39 | $868 | $22 |
| Omeprazole | 51 | $645 | $13 |
| Sotalol | 23 | $455 | $20 |
| Losartan | 14 | $120 | $9 |
| Simvastatin | 13 | $68 | $5 |
| Metoprolol | 12 | $65 | $5 |
| Potassium Chloride | 12 | $48 | $4 |
| Furosemide | 15 | $43 | $3 |
2020: 1 drug
| Metformin | 11 | $50 | $5 |
Money from drug and device companies
$75 in 2025
| 2025 | 1 | 1 | None | $75 |
| 2024 | 1 | 2 | None | $116 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | General - Therapies | $75 | 1 payment
|
See the published payment
| Boston Scientific | Meals · 2025-04-24 | General - Therapies | $75 |
See earlier years (2024)
2024: $116
| Medtronic | Micra | $116 | 2 payments
|
Professional record
- NPI
- 1962960906
- Licence
- CA NP95011315, CA 95176159, OH APRN.CNP.024197, WA AP60937038Washington ARNP.AP.60937038-NP: Expired
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 163W00000X (163W00000X); Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2019-03-08
- NPI last updated
- 2021-01-29
- NPI record certified
- 2021-01-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 900 Miramonte Ave, Mountain View, CA, 94040